These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
472 related articles for article (PubMed ID: 36253712)
21. [Fluoroquinolone resistance determining region mutation in Streptococcus pneumonia isolates]. Zhang FF; Zhao CJ; Wang H Zhonghua Jie He He Hu Xi Za Zhi; 2013 Dec; 36(12):940-4. PubMed ID: 24503427 [TBL] [Abstract][Full Text] [Related]
22. A multiplex single nucleotide polymorphism typing assay for detecting mutations that result in decreased fluoroquinolone susceptibility in Salmonella enterica serovars Typhi and Paratyphi A. Song Y; Roumagnac P; Weill FX; Wain J; Dolecek C; Mazzoni CJ; Holt KE; Achtman M J Antimicrob Chemother; 2010 Aug; 65(8):1631-41. PubMed ID: 20511368 [TBL] [Abstract][Full Text] [Related]
23. A Multicountry Molecular Analysis of Salmonella enterica Serovar Typhi With Reduced Susceptibility to Ciprofloxacin in Sub-Saharan Africa. Al-Emran HM; Eibach D; Krumkamp R; Ali M; Baker S; Biggs HM; Bjerregaard-Andersen M; Breiman RF; Clemens JD; Crump JA; Cruz Espinoza LM; Deerin J; Dekker DM; Gassama Sow A; Hertz JT; Im J; Ibrango S; von Kalckreuth V; Kabore LP; Konings F; Løfberg SV; Meyer CG; Mintz ED; Montgomery JM; Olack B; Pak GD; Panzner U; Park SE; Razafindrabe JL; Rabezanahary H; Rakotondrainiarivelo JP; Rakotozandrindrainy R; Raminosoa TM; Schütt-Gerowitt H; Sampo E; Soura AB; Tall A; Warren M; Wierzba TF; May J; Marks F Clin Infect Dis; 2016 Mar; 62 Suppl 1(Suppl 1):S42-6. PubMed ID: 26933020 [TBL] [Abstract][Full Text] [Related]
24. Activities of newer fluoroquinolones against Streptococcus pneumoniae clinical isolates including those with mutations in the gyrA, parC, and parE loci. Jorgensen JH; Weigel LM; Ferraro MJ; Swenson JM; Tenover FC Antimicrob Agents Chemother; 1999 Feb; 43(2):329-34. PubMed ID: 9925527 [TBL] [Abstract][Full Text] [Related]
25. Genomic profiling of antimicrobial resistance genes in clinical isolates of Salmonella Typhi from patients infected with Typhoid fever in India. Katiyar A; Sharma P; Dahiya S; Singh H; Kapil A; Kaur P Sci Rep; 2020 May; 10(1):8299. PubMed ID: 32427945 [TBL] [Abstract][Full Text] [Related]
26. Development of a Pefloxacin Disk Diffusion Method for Detection of Fluoroquinolone-Resistant Salmonella enterica. Skov R; Matuschek E; Sjölund-Karlsson M; Åhman J; Petersen A; Stegger M; Torpdahl M; Kahlmeter G J Clin Microbiol; 2015 Nov; 53(11):3411-7. PubMed ID: 26292292 [TBL] [Abstract][Full Text] [Related]
27. Prevalence of gyrA Mutations in Nalidixic Acid-Resistant Strains of Salmonella Enteritidis Isolated from Humans, Food, Chickens, and the Farm Environment in Brazil. Campioni F; Souza RA; Martins VV; Stehling EG; Bergamini AMM; Falcão JP Microb Drug Resist; 2017 Jun; 23(4):421-428. PubMed ID: 27559761 [TBL] [Abstract][Full Text] [Related]
28. Mutations in the gyrB, parC, and parE genes of quinolone-resistant isolates and mutants of Edwardsiella tarda. Kim MS; Jun LJ; Shin SB; Park MA; Jung SH; Kim K; Moon KH; Jeong HD J Microbiol Biotechnol; 2010 Dec; 20(12):1735-43. PubMed ID: 21193831 [TBL] [Abstract][Full Text] [Related]
29. Detection of mutations in Salmonella enterica gyrA, gyrB, parC and parE genes by denaturing high performance liquid chromatography (DHPLC) using standard HPLC instrumentation. Randall LP; Coldham NG; Woodward MJ J Antimicrob Chemother; 2005 Oct; 56(4):619-23. PubMed ID: 16141278 [TBL] [Abstract][Full Text] [Related]
30. Novel restriction enzyme SSiI for the detection of mutation in GyrA gene of Salmonella enterica serovar Typhi. Agrawal P; Kapila K; Kumar S; Ghosh AN; Maurya AK Indian J Pathol Microbiol; 2010; 53(3):509-12. PubMed ID: 20699513 [TBL] [Abstract][Full Text] [Related]
31. Decreased susceptibility to fluoroquinolones and gyrA gene mutation in the Salmonella enterica serovar Typhi and Paratyphi A isolated in Katmandu, Nepal, in 2003. Shirakawa T; Acharya B; Kinoshita S; Kumagai S; Gotoh A; Kawabata M Diagn Microbiol Infect Dis; 2006 Apr; 54(4):299-303. PubMed ID: 16466897 [TBL] [Abstract][Full Text] [Related]
32. Increase in nalidixic acid resistance among non-Typhi Salmonella enterica isolates in the United States from 1996 to 2003. Stevenson JE; Gay K; Barrett TJ; Medalla F; Chiller TM; Angulo FJ Antimicrob Agents Chemother; 2007 Jan; 51(1):195-7. PubMed ID: 17088493 [TBL] [Abstract][Full Text] [Related]
33. [Fluoroquinolone resistance mutations in topoisomerase genes of Salmonella typhimurium isolates]. Guo Y; Pei X; Liu X Wei Sheng Yan Jiu; 2004 Sep; 33(5):591-4. PubMed ID: 15612489 [TBL] [Abstract][Full Text] [Related]
34. Molecular Detection of Habeeb Rasool K; Hammood Hussein N; Mahamed Taha B Pak J Biol Sci; 2020 Jan; 23(10):1303-1309. PubMed ID: 32981264 [TBL] [Abstract][Full Text] [Related]
35. Detection of mutations in gyrB using denaturing high performance liquid chromatography (DHPLC) among Salmonella enterica serovar Typhi and Paratyphi A. Gupta R; Gaind R; Singh LC; Paglietti B; Deb M; Rubino S; Wain J; Basir SF Trans R Soc Trop Med Hyg; 2016 Dec; 110(12):684-689. PubMed ID: 28938049 [TBL] [Abstract][Full Text] [Related]
36. Antibiotic susceptibility pattern and the indicator of decreased ciprofloxacin susceptibility of Salmonella enterica serovar Typhi isolated from Dhulikhel Hospital, Nepal. Acharya D; Trakulsomboon S; Madhup SK; Korbsrisate S Jpn J Infect Dis; 2012; 65(3):264-7. PubMed ID: 22627312 [TBL] [Abstract][Full Text] [Related]
37. Mutations in the quinolone resistance determining region in Staphylococcus epidermidis recovered from conjunctiva and their association with susceptibility to various fluoroquinolones. Yamada M; Yoshida J; Hatou S; Yoshida T; Minagawa Y Br J Ophthalmol; 2008 Jun; 92(6):848-51. PubMed ID: 18460536 [TBL] [Abstract][Full Text] [Related]
38. Molecular mechanisms of decreased susceptibility to fluoroquinolones in avian Salmonella serovars and their mutants selected during the determination of mutant prevention concentrations. Kehrenberg C; de Jong A; Friederichs S; Cloeckaert A; Schwarz S J Antimicrob Chemother; 2007 May; 59(5):886-92. PubMed ID: 17369276 [TBL] [Abstract][Full Text] [Related]
39. Characteristics of Resistance Mechanisms and Molecular Epidemiology of Fluoroquinolone-Nonsusceptible Okanda T; Haque A; Ehara T; Huda Q; Ohkusu K; Miah RA; Matsumoto T Microb Drug Resist; 2018 Dec; 24(10):1460-1465. PubMed ID: 29894282 [TBL] [Abstract][Full Text] [Related]
40. gyrA ser83 mutation among fluoroquinolone-resistant Salmonella enterica serovars from enteric fever patients in tertiary care hospital, Kathmandu. Adhikari P; Maharjan R; Paudel S; Malla B; Shah PK; Bastola A; Shrestha UT BMC Microbiol; 2022 Feb; 22(1):51. PubMed ID: 35144539 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]